Omega-3 supplements for pregnant women with HIV
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether taking omega-3 supplements can improve pregnancy outcomes and reduce inflammation in pregnant women living with HIV who are on antiretroviral therapy. If you are between 20 and 29 weeks pregnant with a single baby, you may be eligible to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant with one baby.
- You are between 20 and 29 weeks pregnant (counting from the first day of your last period).
- You are living with HIV and taking antiretroviral therapy.
- You agree to take an omega-3 supplement daily as part of the study.
- You do not have gestational diabetes or preeclampsia at the start.
- You do not smoke or use drugs currently, and you are not allergic to fish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This program provides doula support—a trained companion who offers emotional, physical, and educational help during pregnancy and after birth—for women living with HIV. It aims to support you through your pregnancy and postpartum journey with extra care and guidance.
This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.
This study measures how HIV medicines move through your body during pregnancy by collecting blood samples after you take your regular treatment. It may help improve understanding of dosing and drug levels in pregnant people living with HIV.
This study tests whether a combination of two long-acting HIV medications (cabotegravir and rilpivirine), given as shots every month, is safe and works well for pregnant women who are already taking this treatment. It aims to keep the mother's HIV under control and protect the baby.
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
This study tests if checking DHA (a key omega-3 fatty acid) levels early in pregnancy helps you and your baby. You may get results and guidance to improve your diet.
Hear when a new Pregnant HIV Positive Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.